A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT07340320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar control while taking a steady dose of metformin, with or without a steady dose of an SGLT2 inhibitor, for at least 90 days. The study is being done at multiple medical centers. Participants are assigned by chance (randomized) to different groups, and neither the participants nor the study staff know which group they're in (double-blind). The groups are compared side by side (parallel), and some participants will receive inactive pills (placebo) to help measure the true effect of the study drug. After screening, participants will be randomly placed into one of six groups, with equal chances of being in any group. Each group will receive a different dose of CX11 or a placebo. Treatment will last 24 weeks. After that, all participants will have a 2-week follow-up period to check on safety.
Study identification
- NCT ID
- NCT07340320
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2026
- Primary completion
- Apr 15, 2027
- Completion
- Apr 29, 2027
- Last update posted
- Aug 19, 2026
2026 – 2027
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates - Flourish - PPDS | Birmingham | Alabama | 35205-1605 | Recruiting |
| AES - DRS - Synexus Clinical Research US, Inc. - Birmingham | Birmingham | Alabama | 35211-1320 | Recruiting |
| AES - DRS - Optimal Research Alabama - Huntsville | Huntsville | Alabama | 35802-2569 | Recruiting |
| Core Healthcare Group | Cerritos | California | 90703 | Not yet recruiting |
| Ark Clinical Research - Long Beach | Long Beach | California | 90815-2521 | Recruiting |
| Flourish Research - Walnut Creek - PPDS | Walnut Creek | California | 94598-3343 | Recruiting |
| AES - DRS - Optimal Research Florida - Melbourne | Melbourne | Florida | 32934-8172 | Recruiting |
| Tampa General Hospital | Tampa | Florida | 33606-3571 | Recruiting |
| Conquest Research LLC - Winter Park | Winter Park | Florida | 32789-1857 | Recruiting |
| Privia Medical Group Georgia, LLC - Albany - Javara - PPDS | Albany | Georgia | 31707-0205 | Recruiting |
| Javara Inc. - Fayetteville | Fayetteville | Georgia | 30214 | Recruiting |
| Privia Medical Group Georgia, LLC - Savannah - Javara - PPDS | Savannah | Georgia | 31406-3928 | Recruiting |
| Privia Medical Group Georgia, LLC - Thomasville - Javara - PPDS | Thomasville | Georgia | 31792-6618 | Recruiting |
| AES - DRS - Synexus Clinical Research US, Inc. - Chicago | Chicago | Illinois | 60602-3960 | Recruiting |
| AES - DRS - Synexus Clinical Research US, Inc. - Evansville | Evansville | Indiana | 47714-7513 | Recruiting |
| Privia Medical Group, LLC - Kelly's Collaborative Care - Javara - PPDS | Silver Spring | Maryland | 20901-1586 | Recruiting |
| Elixia Health - Springfield - Elixia - PPDS | Springfield | Massachusetts | 01103 | Recruiting |
| Elixia Health - Michigan Kidney Consultants, LLC - Elixia - PPDS | Pontiac | Michigan | 48341 | Recruiting |
| AES - DRS - Synexus Clinical Research US, Inc. - Edina - Minneapolis | Edina | Minnesota | 55435-4305 | Recruiting |
| Mankato Clinic - East Main Street - Javara - PPDS | Mankato | Minnesota | 56001 | Recruiting |
| Sky Integrative Medical Center | Ridgeland | Mississippi | 39157 | Not yet recruiting |
| Hassman Research Institute - Berlin - CenExel - PPDS | Berlin | New Jersey | 08009 | Recruiting |
| Albuquerque Clinical Trials Inc | Albuquerque | New Mexico | 87102-2619 | Recruiting |
| Brooklyn Clinical Research | Brooklyn | New York | 11226 | Not yet recruiting |
| M3 Wake Research, Inc - M3 WR | Raleigh | North Carolina | 27612-8106 | Recruiting |
| Unity Clinical Research | Oklahoma City | Oklahoma | 73118-2872 | Recruiting |
| Monroe Biomedical Research Charleston | North Charleston | South Carolina | 29406 | Recruiting |
| M3 Wake Research - Dallas | Dallas | Texas | 75246 | Recruiting |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-7202 | Not yet recruiting |
| SMS Clinical Research, LLC - 400 W. Kearney St | Mesquite | Texas | 751497 | Recruiting |
| AES - DRS - Synexus Clinical Research US, Inc. - San Antonio | San Antonio | Texas | 78229-3272 | Recruiting |
| Flourish Research - San Antonio - PPDS | San Antonio | Texas | 78229-3539 | Recruiting |
| Privia Medical Group- North Texas - Stephenville - Javara - PPDS | Stephenville | Texas | 76401-1860 | Recruiting |
| Conquest Research - Arlington | Vienna | Virginia | 22182 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07340320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07340320 live on ClinicalTrials.gov.